Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Immunol. 2012 Mar 30;188(9):4394–4404. doi: 10.4049/jimmunol.1103352

Table II.

KIR2DL4 mutations

Site Motifa KIR Sequenceb Mutated Sequencec
Segments 1–24 GCAGATCCGC
CRE1 TGACGTCA TGACGTAG TAACTTAG; −137, −134
CRE2 TGACGTCA TGACGTAG TAATGTAG; −137, −135
MTE/DPE CSARCSSAAC/RGWYVT CTGGCAGCAGAAGC CTGGTAGGAGTAGC; −16, −13 −10
DCE1 AGC (segment 1 of DCE) AGC TTT; −15 to −13
DCE2 AGC (segment 1 of DCE) AGC ACC; −14
Ets CMGGAWGYd ACATCCTC ACATAATC; −56, −55
dR×1 TGTGGT TGTGGT ACTTGT; −100, −99, −97
dR×2 TGTGGT TGTGGT TGTTGT; −97
dR×3 TGTGGT TGTGGT TGTAGT; −97
pRx TGTGGT ACCACA ATAACA; −62, −61
pRx + Ets CCACWTCCTd,e CCACATCCT TAACATATT; −62, −61, −56, −55
CP2 CNRG(N)5–6 CNRS CCGGTCAGTCGAGCCGAG CCGATCATTCGAGCCGAG; −45, −41
MyoD CANNTG CAGTCG TAGTCT; −43, −38
AP1-A TGASTCA TGATTCA GGCTTCA; −161, −159
AP1-B TGASTCA TGACTGATTCA TGTCGGCTGCA, −163, −161, −159, −157
IRF-2 AAANYGAAA GAAGTGACAA GAGGTGTCAA; −211, −207
GATA-3 WGATAR TGATGT TAACGT; −218, −216

Footnotes:

a

W = A, T; M = A, C; N = A, C, G, T; R = A, G; V =A, C, G; Y = C, T; S = C, G.

b

Underlining denotes mutation target

c

Underlining denotes new base at the position indicated

d

Reference (56)

e

Motif on antisense strand